Pharma updates from the Pharmalot campus via the Pharmalittle newsletter
Alex Hogan/STAT
By Ed Silverman
May 29, 2026
Pharmalot Columnist, Senior Writer
Ed Silverman
The latest pharma news from the Pharmalot campus via the Pharmalittle newsletter is here
The latest pharmaceutical news from the Pharmalot campus via the Pharmalittle newsletter
Drugmakers and patient groups asked the FDA to pause former commissioner Marty Markary's National Priority Voucher drug review…
The latest pharmaceutical news from the Pharmalot campus via the Pharmalittle newsletter
U.S. judge blocked a Colorado state panel from placing a cap on the price of Amgen's blockbuster drug Enbrel
Regenxbio plans to apply for accelerated approval for its gene therapy for Duchenne muscular dystrophy.
